3 Firms Advise Pharmas On $150M Joint Venture
Japanese pharmaceutical firm Shionogi said on Wednesday that it has agreed to create a joint venture with Apnimed, a U.S. company, in a $150 million transaction guided by Allen & Overy...To view the full article, register now.
Already a subscriber? Click here to view full article